Connor, Clark & Lunn Investment Management (CC&L)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,471
Closed -$2.38M 1618
2025
Q4
$2.38M Sell
23,471
-802,788
-97% -$64.5M 0.01% 878
2025
Q3
$45.2M Sell
826,259
-58,378
-7% -$2.92M 0.14% 141
2025
Q2
$47M Buy
884,637
+115,387
+15% +$5.86M 0.17% 113
2025
Q1
$33.3M Buy
769,250
+219,988
+40% +$11.1M 0.15% 123
2024
Q4
$30.9M Buy
549,262
+213,557
+64% +$13.3M 0.14% 118
2024
Q3
$22.9M Buy
335,705
+125,192
+59% +$7.07M 0.11% 149
2024
Q2
$8.89M Buy
+210,513
New +$11.6M 0.04% 298
2024
Q1
Sell
-64,843
Closed -$4.8M 1572
2023
Q4
$4.8M Sell
64,843
-61,504
-49% -$4.03M 0.02% 431
2023
Q3
$8.62M Sell
126,347
-29,376
-19% -$2.49M 0.05% 279
2023
Q2
$14.6M Sell
155,723
-4,228
-3% -$330K 0.07% 200
2023
Q1
$10.8M Buy
+159,951
New +$10.3M 0.06% 235

Other funds holding EXAS

Connor, Clark & Lunn Investment Management (CC&L)'s EXAS Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 23,471 shares — an estimated $2.38M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in EXAS in Q1 2023 and held it in 11 quarters. The position peaked at $47M in Q2 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 23,471 Exact Sciences shares in Q1 2026, an estimated $2.38M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Exact Sciences in Q1 2023 and held it in 11 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Exact Sciences position peaked at $47M in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.